Selected article for: "host cell and human host"
Author: Okeke, Malachy I.; Okoli, Arinze S.; Diaz, Diana; Offor, Collins; Oludotun, Taiwo G.; Tryland, Morten; Bøhn, Thomas; Moens, Ugo
Title: Hazard Characterization of Modified Vaccinia Virus Ankara Vector: What Are the Knowledge Gaps?
  • Document date: 2017_10_29
    • ID: 175igdfk_9
    Snippet: Hazard characterization (ERA step 2) of MVA and MVA-vectored vaccines would require knowledge of: (i) nature and distribution of naturally circulating OPVs that may rescue the MVA during co-infection and superinfection; (ii) recombination between MVA-vectored vaccines and naturally occurring OPVs during co-infection/superinfection of cell cultures, immune-competent and immune-compromised animals; (iii) MVA host restriction in human cells and the .....
    Document: Hazard characterization (ERA step 2) of MVA and MVA-vectored vaccines would require knowledge of: (i) nature and distribution of naturally circulating OPVs that may rescue the MVA during co-infection and superinfection; (ii) recombination between MVA-vectored vaccines and naturally occurring OPVs during co-infection/superinfection of cell cultures, immune-competent and immune-compromised animals; (iii) MVA host restriction in human cells and the molecular basis for the restriction; (iv) clonal purity of MVA stocks; (v) genome and transgene stability of MVA and MVA-vectored vaccines following multiple serial passages; (vi) virus and host factors that modulate transgene stability; (vii) effect of the expressed transgene(s) on the virus-host transcriptome, proteome, metabolome and epigenome and (viii) biodistribution and shedding in immune-competent and immune-compromised individuals.

    Search related documents:
    Co phrase search for related documents
    • cell culture and host factor: 1, 2, 3, 4, 5, 6, 7, 8
    • cell culture and host restriction: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
    • cell culture and human cell: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • cell culture and ii recombination: 1
    • cell culture and molecular basis: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13
    • clonal purity and Hazard characterization: 1, 2
    • co infection and host factor: 1, 2, 3, 4
    • co infection and host restriction: 1, 2
    • co infection and human cell: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
    • co infection and ii recombination: 1, 2
    • co infection and molecular basis: 1, 2
    • Hazard characterization and host restriction: 1
    • Hazard characterization and ii recombination: 1
    • Hazard characterization and molecular basis: 1
    • host factor and human cell: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21
    • host factor and molecular basis: 1, 2
    • host restriction and molecular basis: 1, 2, 3
    • host restriction and multiple serial passage: 1, 2
    • host restriction and MVA human cell host restriction: 1, 2, 3